PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹17,567 Cr | ₹15,369 Cr | ₹14,925 Cr | ₹14,437 Cr | ₹12,717 Cr |
What is the latest Total Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹17,567 Cr |
| Mar2025 | ₹15,369 Cr |
| Mar2024 | ₹14,925 Cr |
| Mar2023 | ₹14,437 Cr |
| Mar2022 | ₹12,717 Cr |
How is Total Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹17,567 Cr | 14.30 | |
| Mar2025 | ₹15,369 Cr | 2.97 | |
| Mar2024 | ₹14,925 Cr | 3.39 | |
| Mar2023 | ₹14,437 Cr | 13.52 | |
| Mar2022 | ₹12,717 Cr | - | |
Compare Total Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,891.7 Cr | 2.3% | 4.9% | -14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 2.3% |
4.9% |
-14.1% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses